Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry

International Journal of Infectious Diseases(2023)10.1016/j.ijid.2023.11.021Source: DataRank Database

Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry is a research paper published in International Journal of Infectious Diseases (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.35)OA: goldTopics (25)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (44)

Samuel Minkove ORCID,Isabel Ruíz-Camps ORCID,Simeón Eremiev ORCID,Gino M Dettorre ORCID,María Laura Fox ORCID

Live enrichment

PubMed:38029831 OpenAlex:https://openalex.org/W4389052910

Cancer Research UK

Grant: 30195

National Institute for Health Research (NIHR)

Grant: CL-2018-18-002

FWCI

0.35

Citation Percentile

0.6%

Citation Trend

2024

2026

goldLicense: cc-by

journalhttp://www.ijidonline.com/article/S1201971223007828/pdf

publisherhttp://www.ijidonline.com/article/S1201971223007828/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1201971223007828?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1201971223007828?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ijid.2023.11.021

Fields of Study

COVID-19 and healthcare impactsCancer Immunotherapy and BiomarkersCOVID-19 Clinical Research Studies

MeSH Terms

Immune Checkpoint InhibitorsCOVID-19COVID-19 TestingHospitalizationHumansMaleNeoplasmsRegistriesRetrospective Studies

Keywords

MedicinePropensity score matchingComorbidityInternal medicineCancerOdds ratioCoronavirus disease 2019 (COVID-19)DiseaseImmunotherapyMalignancyCheckpoint InhibitorCovid-19Sars-cov-2

Sustainable Development Goals

SDG 0: Good health and well-being